Últimas noticias sobre Portage Biotech (NASDAQ:PRTG) Bolsa

Portage Biotech

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

Portage Biotech Inc

Rescheduling is "not a Panacea to all the problems of the industry" and would not make the issue of oversaturation and lack of investor capital go away, Frank Segall, co-chair of cannabis practice at Blank Rome, told the crowd gathered at the <a href="https://www.google.com/url?q=https://www.benzinga.com/events/cannabis-conference/&amp;sa=D&amp;source=docs&amp;ust=1728424361840576&amp;usg=AOvVaw1ND2uKc7pNLpMdV9WsPfvC">Benzinga Cannabis Capital Conference</a> in Chicago on Tuesday. He was part of the panel, &#8220;Consolidation Trends in the Wake of Cannabis Rescheduling: Identifying Winners and Losers.&#8221;
While it would impact positively the balance sheets of many operators by eradicating restrictions of Section 280E of the Internal Revenue Code and attracting some capital, the shift of cannabis to Schedule III would not result in big players like Wells Fargo crossing over to the marijuana industry, Segall said.
"Legalization is what they&#8217;re mandating for them to cross over," he added.
Segall, alongside three other experts, joined the panel moderated by Scott Greiper, founder and president at Viridian Capital Advisors, to discuss broader market consolidation trends following cannabis&#8217;s shift to Schedule III.
Alongside Segall, Pablo Zuanic, managing partner at Zuanic &amp; Associates LLC; Barbara Webb, tax partner at MGO and Laura Bianchi, co-founder of Bianchi &amp; Brandt discussed which types of companies are positioned to thrive and which are not, as well as how investors can identify solid bets in the new regulatory landscape while avoiding pitfalls in a competitive market.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08170959/ccc-oct-24-banner__1_-18.gif" alt="" class="wp-image-586477" /></a></figure>
Zuanic &amp; Associates&#8217; Zuanic said that even though two presidential candidates favor <a href="https://www.benzinga.com/markets/cannabis/24/09/40938172/no-turning-back-now-cannabis-rescheduling-gains-momentum-expert-offers-timeline">rescheduling</a> and a <a href="https://www.benzinga.com/markets/cannabis/24/08/40653233/national-cannabis-roundtable-applauds-deas-move-december-hearing-on-rescheduling-set">DEA hearing</a> on the horizon — with signals the policy shift could happen next year — there's a drop in investor interest in the space. That's compared to the past four years.
"I think that we are getting all a bit ahead of ourselves in terms of optimism here," he said.
Zuanic added the reason why consolidation is not taking place is that valuations are depressed in addition to uncertainty around what rescheduling would really bring. He said the main benefit of rescheduling is making 280E go away.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41237545/exclusive-weed-companies-will-be-treated-like-normal-businesses-once-this-tax-provision-goes-awa">EXCLUSIVE: Weed Companies Will Be Treated Like Normal Businesses Once This Tax Provision Goes Away, Experts Say</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h1 class="wp-block-heading">Not Paying Taxes Is Not A Good Idea: Here's Why</h1>
That said, MGO&#8217;s Webb highlighted many cannabis companies are not paying their taxes, which could be counterproductive for operators if cannabis rescheduling takes place. "It&#8217;s a temporary survival tactic, but you can&#8217;t do that forever," she said, adding "the IRS eventually catches up."
Consequences could seriously affect business growth in the long run.
"You might be able to get an installment plan once they do catch up with you," Webb explained. "However, once on an installment plan, a cannabis business not only have to regularly, never miss a payment pay, but also stay current on your current year&#8217;s estimated taxes, which is a huge cash commitment."
Webb added companies that are going to be "superstars" post-rescheduling are cash flow positive with 280E.
The tactic of not paying taxes will have serious consequences when it comes to M&amp;A activity in the space, Bianchi &amp; Brandt&#8217;s Bianchi said. "That&#8217;s going to have a drastic effect on M&amp;A in the future because it&#8217;s already been an issue," she said.
<h1 class="wp-block-heading">Which Acquisitions Are and Will Be Hot</h1>
Speaking of acquisition targets, Bianchi said some buyers are looking at distressed assets, mainly businesses that have difficulties operationally and are not avoiding paying taxes.
She also said the trend of huge deals is over. "We&#8217;re dealing with more creative companies coming together and maybe joint ventures," Bianchi added.
Zuanic &amp; Associates&#8217; Zuanic said that &#8220;there's too much overlap" in deals where one multi-state operator is buying another one. Instead, he proposes brands as acquisition targets.
Brands are and will be a key point of M&amp;A activity, especially in the scenario where interstate commerce is legal, he continued.
Read Next:
<ul>
<li>EXCLUSIVE: <a href="https://www.benzinga.com/markets/cannabis/24/10/41239355/exclusive-former-congressman-ed-perlmutter-predicts-2024-election-results-and-their-impact-on-ca">Former Congressman Ed Perlmutter Predicts 2024 Election Results And Their Impact On Cannabis Reform</a></li>
</ul>
Photo: Benzinga Cannabis Conference &#8220;Consolidation Trends in the Wake of Cannabis Rescheduling: Identifying Winners and Losers,&#8221; Photo by Wendy Davis.

Cannabis

Government

News

Regulations

Financing

Politics

Legal

Events

EXCLUSIVE: Cannabis Rescheduling Is Not Cure-All For Industry Problems: Experts Explain How Tax Tactics Could Hurt Marijuana Businesses In Long Run

Mikolaichik replaces Interim Chief Financial Officer James Forrester, Jr., who will remain with the Company through the end of the year to help ensure a smooth transition.

Management

PRKS

United Parks & Resorts Names James Mikolaichik To Assume The Role Of CFO And Treasurer Effective Nov. 11, 2024

Benzinga&#8217;s paper trading contest powered by TradeZero is nearing the end of the first of three contests as entrants compete to win over $30,000 in cash and prizes <a href="https://www.tradezeroedge.com/world-championship-of-trading?utm_source=website&amp;utm_medium=editorial&amp;utm_id=trading_competition&amp;utm_content=static" target="_blank" rel="noreferrer noopener">during a monthly contest.</a>
While Contest 1 may be nearly complete, contestants still have a shot at over $25,000 in cash and prizes in two additional contests, with Contest 2 set to kick off on Oct. 15.
Here&#8217;s how you can take home your share of cash and prizes and win a tour of the New York Stock Exchange.
The Contests:&nbsp;Powered by&nbsp;TradeZero, the&nbsp;<a href="https://benzingapartners.go2cloud.org/aff_c?offer_id=467&amp;aff_id=1" target="_blank" rel="noreferrer noopener">World Championship of Trading</a>&nbsp;is the ultimate trading competition for investors to prove their keen eye during a three-month time period.
The first of three separate contests kicked off on Monday, Sept. 16. Contestants had until Monday to sign up for the first contest, which runs through Oct. 14.
Each investor will have around one month across three separate contests to generate the highest profits from a starting balance of $100,000 in a simulated trading account.
Contestants in the World Championship of Trading will have access to Benzinga's Live Squawk product.
Investors will also gain exposure to TradeZero's newly patented short-selling tools.
Here are the top four traders in the first portion of the contest as of Oct. 7:
<ol>
<li>Andrea S: $1,088,390.70</li>
<li>Sneha O.: $366,650.00</li>
<li>Stephen L.: $330,021.80</li>
<li>Benjamin H.: $325,733.04</li>
</ol>
The tenth-place trader has a balance of $217,997.50, meaning the top 10 traders have all gained at least 100% since the contest began.
First Place Held Down: The leaderboard has featured frequent changes among the top 10, but the leader has been fairly consistent. Andrea S. has been in the top 10 for<a href="https://www.benzinga.com/top-stories/24/10/41126924/benzinga-world-championship-of-trading-powered-by-tradezero-contestants-up-90-in-just-2-weeks-join-n"> three weeks straight</a>, with a first-place position in the last two weekly updates. Andrea S. had a balance of $810,808.75 last week, which means she added nearly $200,000 to her contest trading balance over the last trading week.
In an interview with Benzinga, Andrea revealed she is working on her PhD in mathematics and keeping her eyes on the market during the trading contest.
"It's been wild. I didn't expect to end up in first place," Andrea said.
The contestant said she has learned more about finance and trading in recent years and did some internships in the quant trading sector. Andrea said she has applied the things she learned to trading and sought out to see if they would work in a retail trading contest.
"I think I got lucky."
With a goal of winning the contest now, Andrea is now using strategies that are not like her regular trading.
"I'm going to take on much riskier positions."
The trader said they recently bought some call options in the Chinese stock PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) after seeing the stocks was up thanks to news of a China stimulus.
Andrea has also been looking at semiconductor stocks recently, naming Taiwan Semiconductor Manufacturing, NVIDIA Corporation and Super Micro Computer.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Stormy Markets &#x7C; PreMarket Prep" width="500" height="281" src="https://www.youtube.com/embed/DjRmtokM2YQ?start=3615&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Contest Rules:&nbsp;The contest is open to residents of the United States and Canada who are 21 years of age or older.
Traders will be able to buy simulated equities and options from U.S. markets during the contest periods starting with a balance of $100,000. No fractional shares will be allowed. Traders have to hold a minimum of one stock or option throughout the contest. A minimum of five days of one trade or more must be completed throughout each contest.
Interested investors have been able to&nbsp;<a href="https://benzingapartners.go2cloud.org/aff_c?offer_id=467&amp;aff_id=1" target="_blank" rel="noreferrer noopener">sign up to join</a>&nbsp;the contest since Friday, July 26. Signing up for the first contest will automatically register an entry in the second and third contests. Traders can sign up for the contests after the start dates as long as it is before a cutoff deadline.
The dates for the&nbsp;<a href="https://benzingapartners.go2cloud.org/aff_c?offer_id=467&amp;aff_id=1" target="_blank" rel="noreferrer noopener">contests</a>&nbsp;are listed below:
<ul>
<li>Contest 1: Sept. 15 through Oct. 14</li>
<li>Contest 2: Oct. 15 through Nov. 14</li>
<li>Contest 3: Nov. 15 through Dec. 14</li>
</ul>
The last days to register for the contests are Oct. 7, Nov. 7 and Dec. 8 at 9 a.m. ET for the three respective contests.
Read Also:&nbsp;<a href="https://www.benzinga.com/fintech/23/11/35687369/tradezero-ceo-daniel-pipitone-giving-the-retail-traders-an-institutional-level-toolbox" target="_blank" rel="noreferrer noopener">TradeZero CEO Daniel Pipitone: Giving Retail Traders An Institutional-Level Toolbox</a>
Contest Prizes: Participants have the chance to win as much as $30,000 in cash and prizes during the contests. Travel and expenses will not be paid for the NYSE tour prizes.
Here are the contest prizes for the World Championship of Trading.
Contest 1:
<ul>
<li>First Place: $5,000 cash, lifetime of&nbsp;<a href="https://pro.benzinga.com/feature/newsfeed/?gspk=bHVrZWphY29iaTUzNDg&amp;gsxid=tdEE0VrK8Jeg&amp;ref=lukejacobi5348" target="_blank" rel="noreferrer noopener">Benzinga Pro Essential,</a>&nbsp;tour of the NYSE and lunch for two at the NYSE.</li>
<li>Second Place: $1,000 cash, one year of Benzinga Pro Essential.</li>
<li>Third Place: $500 cash, one year of Benzinga Pro Essential.</li>
</ul>
Contest 2:
<ul>
<li>First Place: $10,000 cash, lifetime of Benzinga Pro Essential, tour of the NYSE and lunch for two at the NYSE.</li>
<li>Second Place: $2,000 cash, one year of Benzinga Pro Essential.</li>
<li>Third Place: $1,000 cash, one year of Benzinga Pro Essential.</li>
</ul>
Contest 3:
<ul>
<li>First Place: $15,000 cash, lifetime of Benzinga Pro Essential, tour of the NYSE and lunch for two at the NYSE.</li>
</ul>
Find out more at the&nbsp;<a href="https://benzingapartners.go2cloud.org/aff_c?offer_id=467&amp;aff_id=1" target="_blank" rel="noreferrer noopener">World Championship of Trading site</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/10/41150827/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-september-2024-where-do-tesla-nvidia-apple">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?</a></li>
</ul>

Exclusives

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Benzinga World Championship Of Trading Powered By TradeZero: 1 Contestant Up 988% In 3 Weeks — Join Now For $25,000 In Additional Cash, Prizes

Insurance companies operating in Florida face significant challenges following two intense hurricanes: <a href="https://www.benzinga.com/news/24/10/41231817/hurricane-milton-dire-warning-if-you-choose-to-stay-youre-going-to-die-officials-encourage-writing-n">Helene and Milton</a>. 
What Happened: After Hurricane Helene, losses for private insurers were <a href="https://www.wusf.org/weather/2024-09-25/helene-could-cause-billions-in-private-federal-insurance-losses">estimated</a> at $3 to $6 billion. Hurricane Milton, expected to make landfall Wednesday on Florida's Gulf Coast near Tampa, is adding further strain to Florida&#8217;s insurance market.
High claim volumes, rising premiums and an exodus of insurers already slammed customers. With Hurricane Milton looming, the market could experience further destabilization.
The average annual premium for homeowners' insurance in Florida has surged to $10,996, making it the highest in the nation. 
Insurify <a href="https://insurify.com/homeowners-insurance/report/home-insurance-price-projections/">projects</a> that this number will rise by an additional 7% in 2024, bringing the average to $11,759. This figure is nearly four times the national average, driven by multiple factors including the increased frequency and severity of hurricanes, rising costs of building materials, and issues with reinsurance. 
Florida has also seen a significant number of insurance companies pull out of the state, further exacerbating the situation​.
See Also: <a href="https://www.benzinga.com/news/24/09/41082452/hurricane-helene-exposes-vulnerability-of-floridas-home-insurance-market">Hurricane Helene Exposes Vulnerability Of Florida&#8217;s Home Insurance Market</a>
Stocks To Watch: The <a href="https://www.benzinga.com/markets/equities/24/10/41239644/hurricane-milton-evacuations-a-matter-of-life-and-death-biden-says-feds-bostic-says-storm-could-">ongoing hurricane activity in Florida</a> is expected to impact several major publicly traded insurance companies.
Key insurers facing challenges include: 
<ul>
<li>Allstate Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) </li>
<li>Travelers Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) </li>
<li>Progressive Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) </li>
<li>State Farm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STFGX#NASDAQ">STFGX</a>) </li>
</ul>
Citizens Property Insurance Corp. covers more than 1.4 million policies but with much higher premiums, averaging $21,707 annually​. Dubbed Florida's insurer of last resort, the company is transferring more than 648,000 policies to private insurers, per <a href="https://www.clickorlando.com/news/local/2024/10/04/what-citizens-insurance-depopulation-means-for-florida-homeowners/">Click Orlando</a>.
These companies are experiencing heavy financial strain due to increased claims, which will likely lead to higher premiums and reduced coverage availability. Smaller, regional insurers operating in Florida may also face insolvency or further pressure to exit the market.
Why It Matters: According <a href="https://www.insurancebusinessmag.com/us/news/property/florida-insurers-deny-nearly-half-of-hurricane-claims-ratings-agency-says-508765.aspx">to</a> Insurance Business Magazine, citing Weiss Ratings data, several large Florida insurers denied nearly half of homeowner claims closed in 2023. 
Among these carriers were:
<ul>
<li>Castle Key Indemnity Co., denied 47.1% of claims</li>
<li>Castle Key Insurance Company, at 46%.</li>
<li>State Farm Florida Insurance Company, denied 46.4% </li>
</ul>
Coverage is often denied to conserve cash and avoid bankruptcy.
How We Got Here: While it&#8217;s difficult to attribute any single hurricane directly to climate change, many scientists say that climate change exacerbates the frequency of extreme weather events.
Warmer ocean temperatures, fueled by global warming, provide more energy for storms, making hurricanes such as Helene and Milton more intense.
Rising sea levels also contribute to more severe storm surges. Additionally, changing weather patterns may cause slower-moving storms, leading to more rainfall and prolonged damage in affected areas. Overall, climate change plays a role in the increasing severity of storms.
Florida Gov. Ron DeSantis <a href="https://www.flgov.com/2024/10/08/governor-ron-desantis-issues-updates-on-state-preparedness-efforts-for-hurricane-milton-3/">declared </a>a state of emergency for 51 Florida counties. So far, he has generally avoided directly linking the increasing intensity of hurricanes in <a href="https://www.benzinga.com/topic/climate-change">Florida to climate change</a>.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41236355/stocks-rally-as-oil-prices-tumble-tech-chipmakers-lead-as-traders-focus-on-ai-winners-before-earnin">Stocks Rally As Oil Prices Tumble; Tech, Chipmakers Lead As Traders Focus On AI Winners Before Earnings Season: What&#8217;s Driving Markets Tuesday?</a></li>
</ul>
Photo: Massive destruction on Fort Myers Beach after Hurricane Ian, 2022, by Felix Mizioznikov via Shutterstock

Equities

Insurance

STFGX

Back-To-Back Hurricanes Batter Florida's Insurance Market: Stocks To Watch

THE STOCK RECEIVES ALERT AND REVERSES EARLY DOWNTREND TO CLIMB HIGHER
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="768" height="796" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/08201958/Screen-Shot-2024-10-08-at-4.15.12-PM.png" alt="" class="wp-image-2101" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/08201958/Screen-Shot-2024-10-08-at-4.15.12-PM.png 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/08201958/Screen-Shot-2024-10-08-at-4.15.12-PM-289x300.png 289w" sizes="(max-width: 768px) 100vw, 768px" /></figure>
Honeywell International , Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.&nbsp;
Today, at 10:06 AM on October, 7th, a significant trading signal occurred for Honeywell International, Inc. as it demonstrated a Power Inflow at a price of $207.58. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Honeywell&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Honeywell International, Inc. stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted by active traders as a bullish signal.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for HON, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://finitusa.com/en/">Finit USA</a>, responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:The price at the time of the Power Inflow was $204.39. The returns on the High price ($207.58) and Close price ($207) after the Power Inflow are respectively 1.6% and 1.5%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. The high and close were close but that is not always the case.
Past results are not indicative of future results

Signals

Trading Ideas

General

Tradepulse Power Inflow Alert: Honeywell International Inc. Receives Alert And Rises 1.6% During Trading Day

As the 2024 elections approach, the Marijuana Policy Project (MPP) released its annual voter guide to inform citizens about where their gubernatorial and Senate candidates stand on cannabis policy reform.
With over <a href="https://www.benzinga.com/markets/cannabis/23/11/35674739/marijuana-legalization-support-hits-record-70-as-republicans-join-the-majority-shows-gallup-poll">70%</a> of Americans supporting cannabis legalization, the stakes are high for federal and state-level reform, especially as 11 states will vote for their next governor and 34 Senate seats are up for grabs.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">Why These Elections Matter</h3>
Governors and senators hold significant power over cannabis policy. At the state level, governors can veto or sign cannabis reform bills and direct agencies to either implement or block regulations. Meanwhile, at the federal level, the U.S. Senate is the critical battleground for national reform.&nbsp;
Bills like the <a href="https://www.benzinga.com/markets/cannabis/22/03/26335420/lawmakers-release-report-on-more-act-ahead-of-house-floor-discussion">MORE Act</a> (which seeks to federally legalize cannabis) and the <a href="https://www.benzinga.com/markets/cannabis/24/10/41239355/exclusive-former-congressman-ed-perlmutter-predicts-2024-election-results-and-their-impact-on-ca">SAFE Banking Act</a> (which would grant cannabis businesses access to financial services) have garnered bipartisan support but face a major hurdle: the Senate's filibuster rules.
The filibuster requires 60 votes to move legislation forward, creating a significant barrier to cannabis reform, even though a supermajority of Americans support legalization. With the balance of power in the Senate up for grabs in the November election, the composition of the next Senate will determine whether federal cannabis reform finally has a path forward.
<h3 class="wp-block-heading">What The MPP Voter Guide Covers And How You Can Use It</h3>
The <a href="https://www.mpp.org/">MPP</a> voter guide is more than just an overview of candidate positions, it's a tool for shaping the future of cannabis legalization. By breaking down public statements, voting records and policy positions, the guide allows voters to see clearly where candidates stand on cannabis reform.
Voters can use this information to not only make informed choices at the polls but also target advocacy efforts. If a candidate in your state supports cannabis reform, your vote could help secure their seat and advance legalization. 
If they oppose it, now is the time to make your voice heard through petitions, letters and calls to ensure elected officials know how important cannabis reform is to their constituents.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41233018/exclusive-ross-gerber-sees-tsunami-of-money-pouring-into-cannabis-companies-upon-federal-legaliz">EXCLUSIVE: Ross Gerber Sees &#8216;Tsunami Of Money&#8217; Pouring Into Cannabis Companies Upon Federal Legalization, Says Cannabis Is One Of &#8216;Biggest&#8217; Opportunities Beyond AI</a>
<h3 class="wp-block-heading">Filibuster Schmilibuster: Why Your Vote Can Smoke Out Senate Stalling</h3>
At the federal level, the filibuster has stalled cannabis reform despite growing public support. The MORE Act and SAFE Banking Act are key pieces of legislation that have struggled to gain enough momentum to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/09/34731016/safe-banking-act-headcount-challenge-can-it-reach-60-votes-in-the-senate-analyst-ta">overcome the 60-vote filibuster threshold in the Senate</a>. That's why understanding your senators&#8217; positions is critical.
The <a href="https://www.mpp.org/takeaction/election-central/voter-guides/2024-gubernatorial-cannabis-voter-guide/">MPP guide</a> helps voters determine which senators are blocking reform and which ones are pushing it forward. By using the guide, you can strategically advocate for reform by contacting your senators and urging them to support cannabis legalization. In a closely divided Senate, every vote and every voice matters. This election is an opportunity to break through the Senate's block and make real progress on cannabis reform.
<h2 class="wp-block-heading">Key Races To Watch</h2>
With 24 states and Washington D.C. already legalizing adult-use cannabis, this election could see further expansion in states like Florida, North Dakota, and South Dakota, where voters will decide on cannabis reform initiatives.
Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/10/41237666/exclusive-tax-changes-could-unlock-hundreds-of-millions-in-cash-flow-for-cannabis-sector-experts"> EXCLUSIVE: Tax Changes Could Unlock &#8216;Hundreds Of Millions In Cash Flow&#8217; For Cannabis Sector, Experts Predict</a>
Several key races stand out this year. 
<h3 class="wp-block-heading">Arizona </h3>
In <a href="https://www.benzinga.com/topic/arizona-cannabis">Arizona</a>, Ruben Gallego (D) has been a consistent advocate for federal cannabis legalization, supporting both the MORE Act and the SAFE Banking Act. His opponent, Kari Lake (R), has opposed cannabis reform, providing a clear contrast for voters who support legalization.
<h3 class="wp-block-heading">Florida </h3>
In <a href="https://www.benzinga.com/topic/florida-cannabis">Florida</a>, Debbie Mucarsel-Powell (D) backs Amendment 3, which seeks to legalize adult-use cannabis and has highlighted the barriers Black farmers face in the cannabis industry. Meanwhile, Rick Scott (R) has remained firmly against adult-use legalization and has opposed the SAFE Banking Act, making this race pivotal for cannabis reform in the state.
<h3 class="wp-block-heading">North Dakota </h3>
In <a href="https://www.benzinga.com/topic/north-dakota-cannabis">North Dakota</a>, while voters will consider adult-use legalization, candidates like Kelly Armstrong (R) have voiced opposition to broader cannabis reform, though he has supported banking-related measures. This reflects the divided stance on cannabis issues in the state.
<h3 class="wp-block-heading">D.C. </h3>
At the federal level, Sherrod Brown (D-OH) has been a supporter of cannabis reform, consistently advocating for federal legalization and expanded banking access for cannabis businesses. In contrast, figures like Rick Scott (R) and Ted Cruz (R) of Texas remain staunchly opposed to broader cannabis reforms, including the SAFE Banking Act.
If you're serious about being part of this green wave, the <a href="https://www.mpp.org/takeaction/election-central/voter-guides/2024-us-senate-candidates/">MPP voter guide </a>is your ticket to the insider knowledge that can make a difference. Who's ready to call their senator? Visit <a href="http://www.mpp.org" title="www.mpp.org">www.mpp.org</a> to explore the full guide.&nbsp;
Read Next:<a href="https://www.benzinga.com/markets/cannabis/24/10/41237107/exclusive-curaleafs-boris-jordan-says-cannabis-company-has-made-massive-leap-expects-european-bu"> EXCLUSIVE: Curaleaf&#8217;s Boris Jordan Says Cannabis Company Has Made &#8216;Massive&#8217; Leap, Expects European Business To &#8216;Double&#8217; Next Year Despite Market Risks</a>

Markets

It's Your Constitutional Right: How You Can Break The Senate's Block On Cannabis Legalization

This will be the company&#39;s first property in Kyoto and its third property in Japan.&nbsp;Renovation is anticipated to begin in the&nbsp;second quarter&nbsp;of 2025, with project completion expected in the&nbsp;first quarter&nbsp;of 2026. The start of sales for the property is expected to begin in the&nbsp;second quarter&nbsp;of 2025.

Hilton Grand Vacations Purchases The Citadines Kyoto Karasuma Gojo In Kyoto, Japan; No Terms Disclosed

T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) has outperformed the market over the past 10 years by 11.3% on an annualized basis producing an average annual return of 23.11%. Currently, T-Mobile US has a market capitalization of $246.63 billion. 
Buying $1000 In TMUS: If an investor had bought $1000 of TMUS stock 10 years ago, it would be worth $7,844.35 today based on a price of $211.38 for TMUS at the time of writing.
<h3>T-Mobile US's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728423028_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TMUS

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,800 Today

Reliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RS#NYSE">RS</a>) has outperformed the market over the past 5 years by 9.06% on an annualized basis producing an average annual return of 23.2%. Currently, Reliance has a market capitalization of $15.59 billion. 
Buying $100 In RS: If an investor had bought $100 of RS stock 5 years ago, it would be worth $278.89 today based on a price of $283.46 for RS at the time of writing.
<h3>Reliance's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728423023_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Reliance 5 Years Ago Would Be Worth Today

Media companies are bringing in key figures to help with viewership on the night of the<a href="https://www.benzinga.com/topic/2024-election"> 2024 presidential election.</a>
Two key figures from a hush money trial against former President Donald Trump will be featured in coverage on election night.
What Happened: Stormy Daniels and Michael Cohen are among the key election night featured guests lined up for a media partnership between U.K. broadcaster Channel 4 and U.S. <a href="https://www.benzinga.com/topic/cnn">media company CNN</a>, which is owned by Warner Bros. Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>).
Due to the significance of the 2024 U.S. presidential election and worldwide interest, Channel 4 is devoting eight hours of live programming to the event and utilizing a pact with CNN to help with a lineup of guests.
Channel 4's live programming is set to be hosted by Krishnan Guru-Murthy and Emily Maitlis from Washington D.C., according to a <a href="https://www.hollywoodreporter.com/tv/tv-news/election-2024-cnn-brian-cox-channel-4-1236026602/">report </a>from The Hollywood Reporter.
To help with its "groundbreaking" coverage of the U.S. presidential election, Channel 4 will feature guest stars that include Daniels, Cohen, Caitlyn Jenner, Boris Johnson and Brian Cox.
Channel 4's special is tentatively titled "America Decides: U.S. Election Results." It will air from 10:15 p.m. UK time until early morning.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent100824">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: This marks Channel 4's first overnight coverage of the U.S. election in 32 years, according to the report.
While Channel 4 is publicly owned and relies on advertising, the partnership and guest lineups could put CNN on the radar as seeing potential viewership strength in its U.S. coverage.
"Channel 4's first-ever partnership with CNN will enable the sharing of guests, reporters, graphics and data across the night," Channel 4 said.
While CNN has not announced its full line-up of election night guests, it's quite possible that Daniels, Cohen and other named parties above will be part of it. The sharing of guests between CNN and Channel 4 could help both media companies throughout the day of coverage. CNN will be one of many U.S. companies covering the election outcomes live. 
With their past connections to Trump, Daniels and Cohen could offer a deeper insight into the personal implications for the former president, whether he wins or loses the election.
Both Daniels and Cohen testified against the former president in the hush money trial, where he <a href="https://www.benzinga.com/general/politics/24/05/39100065/trump-found-guilty-on-all-34-counts-in-hush-money-criminal-trial-heres-what-happens-next">was found guilty</a> on 34 counts of falsifying business records.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/09/40754802/trump-hush-money-sentencing-will-now-take-place-after-2024-election-to-avoid-any-appearance-to-a">Trump Hush Money Sentencing Will Now Take Place After 2024 Election: &#8216;To Avoid Any Appearance … To Affect The Approaching Presidential Election&#8217;</a></li>
</ul>
Photo: Shutterstock

Entertainment

Trump's Old Frenemies, Stormy Daniels And Michael Cohen, Go Global With 2024 Election Night Coverage In US, UK

Contracts

Silvercorp Metals Says SGX Mine Permit Has Been Renewed For Another 11 Years With Increased Capacity Of 500,000 Tonnes Per Year

Subsidiary ACO is one of six awardees being announced today for&nbsp;deconversion, with a minimum contract value of&nbsp;$2 million&nbsp;and a maximum value for all awardees of&nbsp;$800 million.&nbsp; The ultimate dollar amount associated with this award will depend upon what task orders ACO is subsequently issued and their value.

Centrus Energy Wins Award From US Department Of Energy To Support Deployment Of Technology And Equipment For HALEU Deconversion

This is an indefinite-delivery, indefinite-quantity contract where future orders will be solicited by DOE from those who received awards, including NFS. The minimum ordering guarantee is&nbsp;$2 million.

BWXT

BWX Technologies Says NFS Subsidiary Was Selected By US Department of Energy As One Of The Successful Bidders For High-Assay Low-Enriched Uranium Deconversion Services

PLTR

SRFM

On October 2, 2024, Surf Air Mobility Issued To Palantir Technologies An Aggregate Of 1.27M Shares Of Common Stock For In-kind Services Worth $1.6M - Filing

Source: <a href="https://www.streetwisereports.com/article/2024/10/04/shallow-high-grade-uranium-mineralization-expands-at-co-s-project.html?utm_medium=feed">Streetwise Reports 10/04/2024</a>
Baselode Energy Corp. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/bsenf#OTC">BSENF</a>) has reported positive uranium assay results from three drill holes of the 2024 drill program at its Ackio prospect, located in the Athabasca Basin, Northern Saskatchewan. These results highlight the shallow depth and high-grade mineralization that continue to characterize the Ackio prospect.
Notably, drill hole AK24-119 intersected 0.28% U3O8 over 21.0 meters, including a high-grade section of 1.55% U3O8 over 1.5 meters at a depth of 141 meters. While drill hole AK24-118 returned 0.59% U3O8 over 8.5 meters, including 1.25% U3O8 over 1.5 meters at a depth of 153 meters.
CEO James Sykes commented in the press release, &quot;These results strengthen our confidence in Ackio. It&#39;s remarkable that, just over three years after discovering Ackio, we&#39;re still achieving better-than-expected grades and widths.&quot;
Baselode expects further assay results from the remaining 40 drill holes to be released after quality review and approval.
<h2>Looking At The Uranium Sector</h2>
The uranium market has experienced notable growth in recent years. As Kitco wrote on September 25, &quot;Despite recent market corrections, uranium and uranium-related equities have outperformed other asset classes over the long term&quot; with the U3O8 uranium spot price seeing significant rises in the last five years. The long-term fundamentals of the market remained strong, with Kitco noting that &quot;global uranium supply lagging behind demand&quot; could lead to higher prices as utilities are &quot;forced to secure long-term contracts.&quot;
<blockquote class="callOut left">Jeff Clark of The Gold Advisor expressed enthusiasm for the company in an October 3 update, stating that the results from the drill program were better than expected, with high-grade uranium intersected in two keyholes.</blockquote>
Chris Temple of The National Investor similarly commented on September 25, &quot;Uranium and nuclear power are clearly back, with long-term demand increasing, driven by significant developments like the restart of nuclear facilities.&quot;
He observed that the sector appeared to be moving past its consolidation phase. He advised, &quot;Now is the time to rebuild exposure to uranium and nuclear power.&quot;
The Financial Times, also writing on September 25, highlighted the impact of the ongoing geopolitical climate on uranium pricing, stating that &quot;the conversion and enrichment prices are reflecting a much bigger supply squeeze due to the Russia-Ukraine war and other factors.&quot; They also pointed to the increasing prices for nuclear fuel, suggesting that &quot;higher nuclear fuel prices are likely to continue as existing conversion facilities face delays.&quot;
<h2>Baselode&#39;s Catalysts</h2>
The Ackio prospect remains a strong catalyst for Baselode Energy&#39;s growth, as the shallow and high-grade uranium mineralization continues to yield favorable results. Baselode&#39;s exploration strategy focuses on near-surface, basement-hosted uranium, which offers the potential for low-cost extraction.
As highlighted in the company&#39;s investor presentation, the Ackio discovery includes nine uranium pods, with mineralization starting as shallow as 25 meters below the surface. The ongoing drilling campaign, which has completed over 30,000 meters since 2021, further enhances the company&#39;s resource potential. With over US$20 million in the treasury, Baselode is well-funded to continue advancing Ackio and other projects, including the Catharsis project currently in drilling.
<h2>What Third-Party Experts Are Saying</h2>
David Talbot, Managing Director at Red Cloud Securities, noted in a September 17 report that drilling at Ackio has &quot;continued to expand the mineralized footprint at Pods 1, 6, and 7&quot; highlighting that &quot;thirteen holes reported composite intervals of anomalous radioactivity between 11m and 42m in thickness.&quot;
In his report, Talbot rated the stock as a Buy and further projected the potential for &quot;8-10-12 million pounds of U3O8 at a grade of ~0.3% U3O8&quot; which aligns with typical grades found in the southeastern part of the Athabasca Basin.
Additionally, Jeff Clark of The Gold Advisor expressed enthusiasm for the company in an October 3 update, stating that the results from the drill program were better than expected, with high-grade uranium intersected in two keyholes. Clark observed that &quot;the stock popped on the news, on heavy volume, investors obviously liking the results.&quot;
He also pointed out that Baselode&#39;s shallow mineralization at Ackio could make future mining operations more economically viable, noting the project&#39;s competitive advantage compared to deeper deposits elsewhere in the Athabasca Basin.
<h2>Ownership and Share Structure</h2>
According to Refinitiv, Baselode has institutions holding 23.26% with Alps Advisors holding the bulk of it with 17.94%, followed by Vident Investment Advisory LLC at 2.97%. Management and Insiders hold 1.59%. The rest is retail.
The company has a market cap of US$12.63 million, according to Market Watch, with 131.51 free float shares. It trades in the 52-week range between US$0.0778 and US$0.4491.
Important Disclosures:
1) James Guttman wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
2) This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports&#39; terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

Penny Stocks

Small Cap

BSENF

Shallow High-Grade Uranium Mineralization Expands at Co.'s Project

Osisko recorded preliminary revenues from royalties and streams of C$57.3 million&nbsp;during the&nbsp;third quarter&nbsp;and preliminary cost of sales (excluding depletion) of C$2.2 million, resulting in a quarterly cash margin&nbsp;of approximately C$55.1 million&nbsp;(or&nbsp;96.3%).
As at September 30th, 2024, Osisko&#39;s cash position was C$58.5 million.&nbsp;The net debt position as of September&nbsp;30, 2024 was reduced to C$22.2 million&nbsp;during the&nbsp;third quarter&nbsp;following debt repayments of C$27.3&nbsp;million.

Osisko Reports 18,408 Attributable Gold Equivalent Ounces In Q3 On Preliminary Basis

AstraZeneca (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/azn#NASDAQ">AZN</a>) announced that it has signed an exclusive license agreement with China-based CSPC Pharmaceutical Group Ltd for developing an early-stage, small molecule Lipoprotein (a) (Lp(a)) disruptor for helping patients with dyslipidaemia.
The latest agreement is likely to strengthen AstraZeneca&#39;s cardiovascular pipeline, which is being studied for treating various cardiovascular diseases.
Year to date, shares of AstraZeneca have rallied 14.1% compared with the industry&#39;s rise of 18.5%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/fa/80674.jpg?v=23295027" />
Image Source: Zacks Investment Research
<h2>More on AZN&#39;s Latest Agreement</h2>
Per the deal, AZN will make an upfront payment of $100 million to CSPC. The company is also entitled to pay up to $1.92 billion for further development and commercialization milestones plus tiered royalties to CSPC.
Per the latest agreement with CSPC, AstraZeneca will gain access to the latter&#39;s pre-clinical candidate, YS2302018, an oral Lp(a) disruptor, and develop the same for various cardiovascular diseases. The company will develop YS2302018 alone or in combination studies, including with the oral small molecule PCSK9 inhibitor, AZD0780.
Discovered by CSPC, YS2302018 has been shown to effectively prevent the formation of Lp(a), a form of low-density lipoprotein&nbsp;that plays a key role in transporting cholesterol in the bloodstream.
Per the company, the addition of YS2302018 to AZN&#39;s cardiovascular pipeline might help patients to more effectively manage their dyslipidaemia and cardiometabolic diseases.
<h2>AZN&#39;s Airsupra Meet Goal in BATURA Study</h2>
In a separate press release, AstraZeneca announced positive data from the phase IIIb BATURA study, which evaluated its pressurized metered-dose inhaler (pMDI), Airsupra (albuterol/budesonide).
Data from the study showed that treatment with Airsupra led to a statistically significant and clinically meaningful reduction in the risk of a severe exacerbation when used as an as-needed rescue medication in response to symptoms versus as-needed albuterol in patients with intermittent or mild persistent asthma. This was the primary endpoint of the BATURA study.
Airsupra is approved for as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and above in the United States. It is the first and only anti-inflammatory rescue medication for the given condition.
<h2>AZN&#39;s Zacks Rank &amp; Other Stocks to Consider</h2>
AstraZeneca currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the biotech sector are ANI Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anip#NASDAQ">ANIP</a>), ADMA Biologics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adma#NASDAQ">ADMA</a>) and Alnylam Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alny#NASDAQ">ALNY</a>), each sporting a Zacks Rank #1 (Strong Buy) at present. In the past 60 days, estimates for ANI Pharmaceuticals&#39; 2024 earnings per share have moved up from $4.53 to $4.81. Earnings per share estimates for 2025 have improved from $5.38 to $5.86. Year to date, shares of ANIP have increased 1.3%.
ANIP&#39;s earnings beat estimates in each of the trailing four quarters, with the average surprise being 31.32%.
In the past 60 days, estimates for ADMA Biologics&#39; 2024 earnings per share have increased from 35 cents to 49 cents. Earnings per share estimates for 2025 have improved from 53 cents to 64 cents. Year to date, shares of ADMA have surged 346.5%.
ADMA&#39;s earnings beat estimates in each of the trailing four quarters, with the average surprise being 105.63%.
In the past 60 days, estimates for Alnylam&#39;s 2024 loss per share have narrowed from $1.20 to 63 cents. Loss per share estimates for 2025 have narrowed from 34 cents to 27 cents. Year to date, shares of ALNY have rallied 39.4%.
ALNY&#39;s earnings beat estimates in each of the trailing four quarters, with the average surprise being 108.53%.
<a href="https://www.zacks.com/stock/news/2347767/astrazeneca-inks-agreement-to-boost-cardiovascular-pipeline?cid=CS-BENZ-FT-analyst_blog|company_news_medical_sector-2347767">To read this article on Zacks.com click here.</a>

Biotech

Earnings

Earnings Beats

Large Cap

Mid Cap

Analyst Ratings

ADMA

ALNY

ANIP

AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline

8 analysts have expressed a variety of opinions on NMI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMIH#NASDAQ">NMIH</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $44.25, a high estimate of $48.00, and a low estimate of $40.00. Observing a 12.74% increase, the current average has risen from the previous average price target of $39.25. 
<img src="https://www.benzinga.com/files/images/story/2024/1728421255_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The analysis of recent analyst actions sheds light on the perception of NMI Holdings by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Terry Ma</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$48.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$46.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$48.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Bose George</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$40.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Terry Ma</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$43.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$42.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$40.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Mark Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$47.00</td>
<td>$37.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to NMI Holdings. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of NMI Holdings compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of NMI Holdings's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of NMI Holdings's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/NMIH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on NMI Holdings analyst ratings.</a>
<h2>Get to Know NMI Holdings Better</h2>
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.
<h3>NMI Holdings's Financial Performance</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: NMI Holdings's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 13.62%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: NMI Holdings's net margin is impressive, surpassing industry averages. With a net margin of 56.8%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): NMI Holdings's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.58% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): NMI Holdings's ROA stands out, surpassing industry averages. With an impressive ROA of 3.02%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: NMI Holdings's debt-to-equity ratio is below the industry average. With a ratio of 0.2, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NMIH

In-Depth Examination Of 8 Analyst Recommendations For NMI Holdings

5 analysts have shared their evaluations of PennyMac Financial Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFSI#NYSE">PFSI</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $116.8, with a high estimate of $125.00 and a low estimate of $102.00. Marking an increase of 6.96%, the current average surpasses the previous average price target of $109.20. 
<img src="https://www.benzinga.com/files/images/story/2024/1728421248_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The perception of PennyMac Financial Servs by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Devries</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$125.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Crispin Love</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$125.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Jay McCanless</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$120.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Crispin Love</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$112.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>George Bose</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$102.00</td>
<td>$102.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to PennyMac Financial Servs. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of PennyMac Financial Servs compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of PennyMac Financial Servs's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into PennyMac Financial Servs's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PFSI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on PennyMac Financial Servs analyst ratings.</a>
<h2>Get to Know PennyMac Financial Servs Better</h2>
PennyMac Financial Services Inc is a United States-based financial services company primarily engaged in mortgage lending. The company operates through three segments: production, servicing, and investment management. The company's production and servicing segment together form the mortgage banking business that includes mortgage loan origination, acquisition, and sale activities; while the investment management segment includes investment manager's activities, such as performing diligence, and managing acquired assets. The company generates the majority of revenue from its mortgage banking business.
<h3>Financial Insights: PennyMac Financial Servs</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: PennyMac Financial Servs's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 25.43%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 13.74%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): PennyMac Financial Servs's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.72% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): PennyMac Financial Servs's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.47%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: PennyMac Financial Servs's debt-to-equity ratio is below the industry average. With a ratio of 4.47, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PFSI

5 Analysts Have This To Say About PennyMac Financial Servs

10 analysts have expressed a variety of opinions on Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $88.3, a high estimate of $135.00, and a low estimate of $57.00. Marking an increase of 1.88%, the current average surpasses the previous average price target of $86.67. 
<img src="https://www.benzinga.com/files/images/story/2024/1728421237_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Cloudflare. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew DeGasperi</td>
<td>Exane BNP Paribas</td>
<td>Announces</td>
<td>Underperform</td>
<td>$65.00</td>
<td>-</td>
</tr>
<tr>
<td>Aaron Samuels</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Neutral</td>
<td>$85.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$99.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>John Difucci</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Sell</td>
<td>$57.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Shrenik Kothari</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>Yi Fu Lee</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$85.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>James Fish</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$83.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Alex Henderson</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$135.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Gregg Moskowitz</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$92.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>James Fish</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$81.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Cloudflare. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cloudflare compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Cloudflare's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Cloudflare's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NET/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Cloudflare analyst ratings.</a>
<h2>Delving into Cloudflare's Background</h2>
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
<h3>Financial Milestones: Cloudflare's Journey</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Cloudflare displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 29.98%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Cloudflare's net margin excels beyond industry benchmarks, reaching -3.76%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Cloudflare's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -1.8%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Cloudflare's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.53%, the company showcases efficient use of assets and strong financial health.
Debt Management: Cloudflare's debt-to-equity ratio is below the industry average. With a ratio of 1.63, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Navigating 10 Analyst Ratings For Cloudflare

Portage Biotech Inc (PRTG) has released an update. Portage Biotech Inc. has announced a 1-for-20 reverse stock split to raise its per-share trading...

Portage Biotech Initiates Reverse Stock Split

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!



Moving stocks this morning are earnings reports, a stock offering, a reverse stock split and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Digital Ally (NASDAQ:<a href="https://investorplace.com/stock-quotes/dgly-stock-quote/">DGLY</a>) stock is rocketing more than 107% alongside heavy pre-market trading.</li>



<li>Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) shares are soaring over 53% with the <a href="https://www.nasdaq.com/press-release/viracta-therapeutics-reports-second-quarter-2024-financial-results-and-provides">release of its Q2 earnings report</a>.</li>



<li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) stock is surging more than 42% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318518494&amp;type=PDF&amp;symbol=CDT&amp;cdn=197541151657f71d6ed19abcc1e0e48e&amp;companyName=Conduit+Pharmaceuticals+Inc.&amp;formType=3&amp;formDescription=Initial+statement+of+beneficial+ownership+of+securities&amp;dateFiled=2024-08-13">an investment update</a>.</li>



<li>Nuburu (NYSEMKT:<a href="https://investorplace.com/stock-quotes/buru-stock-quote/">BURU</a>) shares are rising over 26% despite a lack of news this morning.</li>



<li>Jianzhi Education Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/jz-stock-quote/">JZ</a>) stock is gaining close to 19% even with a <a href="https://www.nasdaq.com/press-release/jianzhi-education-technology-group-company-limited-receives-nasdaq-notification-0">recent delisting notice</a>.</li>



<li>Edible Garden (NASDAQ:<a href="https://investorplace.com/stock-quotes/edbl-stock-quote/">EDBL</a>) shares are increasing more than 18% on <a href="https://www.nasdaq.com/press-release/edible-garden-reports-157-increase-gross-profit-fueled-year-over-year-growth-61-cut">strong Q2 earnings</a>.</li>



<li>Ucloudlink (NASDAQ:<a href="https://investorplace.com/stock-quotes/ucl-stock-quote/">UCL</a>) stock is heading over 16% higher with its <a href="https://www.nasdaq.com/press-release/ucloudlink-group-inc-announces-unaudited-second-quarter-2024-financial-results-2024">most recent earnings report</a>.</li>



<li>Vertex Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtnr-stock-quote/">VTNR</a>) shares are jumping 16% with strong early morning trading.</li>



<li>Serve Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/serv-stock-quote/">SERV</a>) stock is climbing more than 15% with its <a href="https://www.stocktitan.net/news/SERV/serve-robotics-announces-second-quarter-2024-wqwtqr037uv4.html">Q2 earnings report</a>.</li>



<li>Kamada (NASDAQ:<a href="https://investorplace.com/stock-quotes/kmda-stock-quote/">KMDA</a>) shares are up over 15% after posting <a href="https://www.nasdaq.com/press-release/kamada-reports-strong-second-quarter-and-first-half-2024-financial-results-year-over">positive Q2 earnings results</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>TC BioPharm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock is crashing more than 42% after <a href="https://www.nasdaq.com/press-release/tc-biopharm-announces-pricing-20-registered-direct-offering-2024-08-13">pricing a registered direct offering</a>.</li>



<li>Surgepays (NASDAQ:<a href="https://investorplace.com/stock-quotes/surg-stock-quote/">SURG</a>) shares are plummeting over 26% after <a href="https://www.prnewswire.com/news-releases/surgepays-announces-second-quarter-2024-financial-results-302221503.html">reporting a Q2 loss</a>.</li>



<li>Arcadia Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/rkda-stock-quote/">RKDA</a>) stock is diving more than 16% after <a href="https://markets.businessinsider.com/news/stocks/rkda-stock-earnings-arcadia-biosciences-for-q2-of-2024-1033684150">missing Q2 EPS estimates</a>.</li>



<li>Ouster (NYSE:<a href="https://investorplace.com/stock-quotes/oust-stock-quote/">OUST</a>) shares are taking an over 16% beating on <a href="https://www.businesswire.com/news/home/20240813944318/en/Ouster-Reports-Strong-Revenue-and-Margins-for-Second-Quarter-2024">mixed Q2 earnings</a>.</li>



<li>QuickLogic (NASDAQ:<a href="https://investorplace.com/stock-quotes/quik-stock-quote/">QUIK</a>) stock is tumbling more than 16% with its <a href="https://www.prnewswire.com/news-releases/quicklogic-reports-41-year-over-year-revenue-growth-for-second-quarter-fiscal-2024-302221555.html">latest earnings release</a>.</li>



<li>Brinker International (NYSE:<a href="https://investorplace.com/stock-quotes/eat-stock-quote/">EAT</a>) shares are sliding over 16% after <a href="https://www.investing.com/news/stock-market-news/brinker-international-stock-tumbles-13-on-q4-earnings-miss-93CH-3570960">posting an earnings miss</a>.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) stock is falling more than 15% after <a href="https://www.stocktitan.net/news/PRTG/portage-biotech-announces-1-for-20-reverse-stock-sficaewojjpr.html">announcing a reverse stock split</a>.</li>



<li>Global E Online (NASDAQ:<a href="https://investorplace.com/stock-quotes/glbe-stock-quote/">GLBE</a>) shares are decreasing over 14% with its <a href="https://www.stocktitan.net/news/GLBE/global-e-reports-second-quarter-2024-1dq5hcfetvn1.html">Q2 earnings report</a>.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) stock is dropping more than 14% without any clear news this morning.</li>



<li>WISeKey (NASDAQ:<a href="https://investorplace.com/stock-quotes/wkey-stock-quote/">WKEY</a>) shares close out our pre-market stock movers down nearly 14% on a <a href="https://www.nasdaq.com/press-release/sealcoin-secures-50-million-investment-commitment-gem-digital-limited-through-0">new investment</a> <a href="https://www.nasdaq.com/press-release/wisekey-partners-venafi-post-quantum-encryption-services-2024-08-14">and partnership</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-aug-14th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Portage Biotech Inc (PRTG) has released an update. Portage Biotech Inc. has announced a significant reduction in net loss from $104.7 million to $7...

Portage Biotech Navigates Strategic Changes Amid Loss Reduction

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) just reported results for the fourth quarter of 2024.<ul><li>Portage Biotech reported earnings per share of -$1.21.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/prtg-stock-earnings-portage-biotech-for-q4-of-2024/">PRTG Stock Earnings: Portage Biotech Reported Results for Q4 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

PRTG Stock Earnings: Portage Biotech Reported Results for Q4 2024

Portage Biotech GAAP EPS of -$3.89

Portage Biotech Inc (PRTG) has released an update. Portage Biotech Inc. has released its financial statements for the three months ending June 30, ...

Portage Biotech Releases Q2 2024 Financials

Portage Biotech Inc (PRTG) has released an update. Portage Biotech Inc. has reported a significant decrease in net loss for the fiscal quarter ende...

Portage Biotech Reports Decreased Quarterly Loss

Portage Biotech Inc (PRTG) has released an update. Portage Biotech Inc. has successfully regained compliance with the Nasdaq's minimum bid price re...

Portage Biotech Regains Nasdaq Compliance

Stocks are slightly lower this afternoon, as investors hope for the Federal Open Market Committee (FOMC) to issue its first interest rate cut in four years later today.

Wall Street Lower Ahead Of Interest Rate Move

Portage Biotech Inc (PRTG) has released an update. Portage Biotech Inc. announced significant management changes as former CFO Allan Shaw and accou...

Comments

Portage Biotech

Noticias

Últimas noticias sobre Portage Biotech (NASDAQ:PRTG) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL